AR063263A1 - Agentes tensioactivos reconstituidos - Google Patents

Agentes tensioactivos reconstituidos

Info

Publication number
AR063263A1
AR063263A1 ARP070104520A ARP070104520A AR063263A1 AR 063263 A1 AR063263 A1 AR 063263A1 AR P070104520 A ARP070104520 A AR P070104520A AR P070104520 A ARP070104520 A AR P070104520A AR 063263 A1 AR063263 A1 AR 063263A1
Authority
AR
Argentina
Prior art keywords
amino acid
group
value
acid residue
integer
Prior art date
Application number
ARP070104520A
Other languages
English (en)
Spanish (es)
Inventor
Jan Johansson
Bengt Robertson
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR063263(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of AR063263A1 publication Critical patent/AR063263A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
ARP070104520A 2006-10-13 2007-10-11 Agentes tensioactivos reconstituidos AR063263A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13

Publications (1)

Publication Number Publication Date
AR063263A1 true AR063263A1 (es) 2009-01-14

Family

ID=39079026

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP070104520A AR063263A1 (es) 2006-10-13 2007-10-11 Agentes tensioactivos reconstituidos
ARP180103211A AR113422A2 (es) 2006-10-13 2018-11-05 Agentes tensioactivos reconstituidos que tienen propiedades mejoradas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP180103211A AR113422A2 (es) 2006-10-13 2018-11-05 Agentes tensioactivos reconstituidos que tienen propiedades mejoradas

Country Status (35)

Country Link
US (2) US8183210B2 (https=)
EP (1) EP2078038B1 (https=)
JP (2) JP5405307B2 (https=)
KR (1) KR101328851B1 (https=)
CN (2) CN103169947B (https=)
AR (2) AR063263A1 (https=)
AU (1) AU2007306075B2 (https=)
BR (1) BRPI0715317B1 (https=)
CA (1) CA2666344C (https=)
CL (1) CL2007002931A1 (https=)
CO (1) CO6400235A2 (https=)
CY (1) CY1114716T1 (https=)
DK (1) DK2078038T3 (https=)
EA (1) EA015802B1 (https=)
ES (1) ES2438727T3 (https=)
GE (1) GEP20125531B (https=)
HR (1) HRP20140052T1 (https=)
IL (1) IL198075A (https=)
JO (1) JO2963B1 (https=)
MA (1) MA31062B1 (https=)
ME (2) ME02326B (https=)
MX (1) MX343064B (https=)
MY (1) MY148127A (https=)
NO (1) NO342038B1 (https=)
NZ (1) NZ576189A (https=)
PE (1) PE20081184A1 (https=)
PL (1) PL2078038T3 (https=)
PT (1) PT2078038E (https=)
RS (1) RS53172B (https=)
SI (1) SI2078038T1 (https=)
TN (1) TN2009000099A1 (https=)
TW (1) TWI388333B (https=)
UA (1) UA94477C2 (https=)
WO (1) WO2008044109A1 (https=)
ZA (1) ZA200902481B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563683B2 (en) 2006-07-20 2013-10-22 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
EP3459556A1 (en) 2012-02-09 2019-03-27 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Synthetic analogs of lung surfactant protein sp-c and their use
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
AR093569A1 (es) 2012-11-21 2015-06-10 Chiesi Farm Spa Tensioactivos pulmonares reconstituidos
CA3008646A1 (en) 2015-12-17 2017-06-22 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
WO2017155857A1 (en) 2016-03-07 2017-09-14 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center COMPOSITIONS AND METHODS FOR ADMINISTERING PPARγ AGONISTS, SURFACTANT PEPTIDES AND PHOSPHOLIPIDS
KR102395835B1 (ko) * 2016-08-24 2022-05-10 키에시 파르마슈티시 엣스. 피. 에이. 재구성된 폐 계면활성제 조성물을 포함하는 안정한 약제학적 제제
US12606609B2 (en) 2020-01-28 2026-04-21 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
US20240025970A1 (en) * 2020-10-16 2024-01-25 Sherwood Russ Lehrman Lung treatment compositions
WO2025024609A1 (en) * 2023-07-25 2025-01-30 Biosuperior Technology, Inc. Polypeptides for lung surfactant compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163860A1 (en) * 1993-06-30 1995-01-12 Chung C. Hsu Method for preparing liposomes
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
US8563683B2 (en) * 2006-07-20 2013-10-22 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
PT2078038E (pt) 2013-12-12
CY1114716T1 (el) 2016-10-05
NO342038B1 (no) 2018-03-19
US9238058B2 (en) 2016-01-19
NZ576189A (en) 2011-09-30
BRPI0715317A2 (pt) 2013-07-09
IL198075A (en) 2016-04-21
AR113422A2 (es) 2020-04-29
ZA200902481B (en) 2010-07-28
DK2078038T3 (da) 2013-12-02
CN101522711A (zh) 2009-09-02
KR101328851B1 (ko) 2013-11-14
AU2007306075A1 (en) 2008-04-17
MA31062B1 (fr) 2010-01-04
CN101522711B (zh) 2013-11-13
IL198075A0 (en) 2011-08-01
ES2438727T3 (es) 2014-01-20
EP2078038A1 (en) 2009-07-15
PE20081184A1 (es) 2008-09-26
BRPI0715317B1 (pt) 2021-10-05
HK1185274A1 (en) 2014-02-14
EA200900373A1 (ru) 2009-10-30
CL2007002931A1 (es) 2008-03-24
US20100004173A1 (en) 2010-01-07
CA2666344C (en) 2017-04-18
JP2010505937A (ja) 2010-02-25
AU2007306075B2 (en) 2012-08-09
JP2013241449A (ja) 2013-12-05
ME02326B (me) 2016-06-20
UA94477C2 (ru) 2011-05-10
JO2963B1 (en) 2016-03-15
MEP12109A (en) 2011-12-20
MX343064B (es) 2016-10-24
TN2009000099A1 (en) 2010-08-19
SI2078038T1 (sl) 2014-02-28
HK1134497A1 (en) 2010-04-30
MY148127A (en) 2013-02-28
PL2078038T3 (pl) 2014-05-30
US20130079275A1 (en) 2013-03-28
KR20090083892A (ko) 2009-08-04
TWI388333B (zh) 2013-03-11
MX2009003638A (es) 2009-04-22
NO20091441L (no) 2009-06-23
WO2008044109A1 (en) 2008-04-17
EP2078038B1 (en) 2013-11-20
GEP20125531B (en) 2012-05-25
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
EA015802B1 (ru) 2011-12-30
CN103169947A (zh) 2013-06-26
HRP20140052T1 (hr) 2014-02-28
US8183210B2 (en) 2012-05-22
CA2666344A1 (en) 2008-04-17
RS53172B (sr) 2014-06-30
JP5405307B2 (ja) 2014-02-05
TW200824705A (en) 2008-06-16

Similar Documents

Publication Publication Date Title
AR063263A1 (es) Agentes tensioactivos reconstituidos
AR076973A1 (es) Composicion tensioactiva reconstituida mejorada que contiene analogos de la proteina tensioactiva b (sp-b) y de la proteina tensioactiva c (sp-c)
BRPI0811320A2 (pt) Surfactantes reconstituídos com propriedades melhoradas
CY1123901T1 (el) Φαρμακευτικη συνθεση και χορηγησεις αυτης
MX9205985A (es) Epitopes de las celulas t de los alergenos principales del genero dermatophagoides y composiciones farmaceuticas que los contienen.
IL210668A (en) Glucagon-like peptide-2 (2-glp) analogues and their pharmaceutical preparations
PT2121731E (pt) Vacinas peptídicas para cancros que expressam antigénios associados a tumores
UY27038A1 (es) Agonistas selectivos del receptor ep4 en el tratamiento de la osteoporosis
ATE232109T1 (de) Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung
SV2010003599A (es) Polvo nutricional estable
SE0301009D0 (sv) Novel compounds
CO6231039A2 (es) Composiciones que comprenden anticuerpo que se fija al dominio ii de her2 y sus variantes acidas
PE20141159A1 (es) Metodos para tratar o prevenir trastornos relacionados con el colesterol
ATE417610T1 (de) Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
MX2020008096A (es) Peptidos de la cadena b de la relaxina lipidados modificados y su uso terapeutico.
AR004158A1 (es) Compuesto de ftalizin-pirido dionas; composición farmacéutica que lo contiene; y proceso para la preparación de dicho compuesto.
BRPI0514411A (pt) formulação, e, método de produzir uma formulação
BRPI0414868A (pt) composições e métodos compreendendo compostos relacionados com prostaglandina e peptìdios da famìlia do fator trifoliado para o tratamento de glaucoma com hiperemia reduzida
MX167469B (es) Metodo para purificar polidextrosa y composicion que la contiene
PL1907519T3 (pl) Zastosowanie fulerenu C60 jako stabilizatora olejów zawierających fosfoglicerydy
NO20063521L (no) Blandinger, fremgangsmater og anvendelser av en ny peptidfamilie
CL2024002433A1 (es) Agente de batido en polvo que tiene funcionalidad mejorada
KR930012023A (ko) 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법
MX169075B (es) Composicion cosmetica para el cabello
UY27821A1 (es) Derivdos de nitrosodifenilamina, composiciones que los contienen, y su uso como antioxidantes y donores espontaneos de oxido nitrico.

Legal Events

Date Code Title Description
FC Refusal